Dudediligence.

bioAffinity Technologies, Inc

BIAFNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Price

From the filings

Figures

Revenue
$5.9Mlast 12 months
Net income
−$15.2Mlast 12 months
Operating cash flow
−$10.9Mlast 12 months
Cash and equivalents
$2.4Mat the last balance sheet
Shares outstanding
6.8M shareson issue
Every year and quarter →